Keyphrases
Finland
100%
Confidence Interval
56%
Prostate Cancer
42%
Type 1 Diabetes Mellitus (T1DM)
28%
Type I Diabetes
27%
Young Finns Study
26%
Risk Factors
24%
Cardiovascular Risk
22%
Meta-analysis
22%
Register Study
19%
Hazard Ratio
18%
Adulthood
18%
Randomized Controlled Trial
18%
Tampere
17%
Prostate Cancer Risk
16%
Celiac Disease
16%
Odds Ratio
16%
Tumor
16%
Genome-wide Association Study
16%
Body Mass Index
15%
University Hospital
15%
Carbonic Anhydrase
14%
High Risk
13%
National Cohort Study
13%
Health-related Quality of Life
13%
COVID-19
12%
Overall Survival
12%
Population-based Study
12%
Comorbidity
12%
Nationwide Registers
12%
Asthma
11%
Population-based
11%
Quality of Life
11%
Cardiovascular Disease
11%
Blood Pressure
10%
Older Adults
10%
Coronary Artery Disease
10%
Magnetic Resonance Imaging
10%
Islet Autoimmunity
10%
Preeclampsia
10%
COVID-19 Pandemic
10%
Diabetes
9%
Arthroplasty Register
9%
Cardiomyocytes
9%
Colorectal Cancer
9%
Retrospective Cohort Study
9%
Physical Activity
8%
Systematic Meta-analysis
8%
Atrial Fibrillation
8%
During Pregnancy
8%
Incidence Rate
8%
Sweden
8%
Randomized Trial
8%
Non-associated
8%
Total Hip Arthroplasty
8%
Traumatic Brain Injury
8%
Lynch Syndrome
8%
Autoantibodies
8%
Randomized Clinical Trial
8%
Inflammation
7%
Avidin
7%
Breast Cancer
7%
Obesity
7%
Induced Pluripotent Stem Cells (iPSCs)
7%
Hospitalization
7%
Ovarian Cancer
7%
Severe Asthma
7%
Adjusted Odds Ratio
7%
Computed Tomography
7%
Gestational Diabetes
7%
DNA Methylation (DNAm)
7%
1-year Follow-up
6%
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
6%
Antibiotics
6%
Acute Coronary Syndrome
6%
MicroRNA
6%
Gene Expression
6%
Genotype
6%
Periprosthetic Joint Infection
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Radiotherapy
6%
All-cause Mortality
6%
Cardiovascular Mortality
6%
Placebo
6%
Enterovirus
6%
Prognostic Factors
6%
Single Center
6%
Clinical Trials
6%
Multivariable
6%
Prostate Cancer Screening
6%
High-risk Human Papillomavirus (HR-HPV)
6%
Single nucleotide Polymorphism
6%
Talin
6%
Nordic Countries
6%
Inflammatory Bowel Disease
6%
Carotid Intima-media Thickness (cIMT)
6%
Etiology
6%
Clinical Outcomes
6%
Clinically Significant
6%
Europe
6%
Medicine and Dentistry
Prostate Cancer
43%
Diseases
33%
Cohort Analysis
33%
Neoplasm
29%
Diagnosis
24%
Quality of Life
21%
Malignant Neoplasm
19%
Randomized Controlled Trial
19%
Prevalence
19%
Odds Ratio
19%
Cancer
18%
Hazard Ratio
17%
Systematic Review
17%
Meta-Analysis
15%
Biological Marker
15%
Breast Cancer
14%
Insulin Dependent Diabetes Mellitus
14%
Cardiovascular Risk
13%
Arthroplasty
13%
Pediatrics
13%
Cardiovascular System
13%
Arm
13%
Apoplexy
13%
Magnetic Resonance Imaging
13%
Overall Survival
13%
Infection
13%
Body Mass Index
12%
COVID-19
12%
Surgery
11%
Retrospective Cohort Study
11%
Asthma
11%
Adolescence
10%
Comorbidity
10%
Colorectal Carcinoma
10%
Health Care Cost
10%
Total Hip Arthroplasty
10%
Computer Assisted Tomography
10%
Cancer Cell
9%
Brain Ischemia
9%
Randomized Clinical Trial
9%
Ovarian Cancer
9%
Cardiovascular Disease
9%
Health Care
9%
Diabetes
9%
Atrial Fibrillation
8%
Logistic Regression Analysis
8%
Radiation Therapy
8%
Electrocardiogram
8%
Adverse Event
8%
Traumatic Brain Injury
8%
Placebo
8%
In Vitro
8%
Intensive Care Unit
8%
Neonatal Infant
8%
Pre-Eclampsia
8%
Blood Pressure
8%
Triage
7%
Reoperation
7%
Proportional Hazards Model
7%
Total Knee Arthroplasty
7%
Coeliac Disease
7%
Physical Activity
7%
Atherosclerosis
7%
Cytopathology
7%
Cardiac Muscle Cell
7%
Lung
7%
Injury
7%
Coronary Artery Disease
7%
Bleeding
7%
Observational Study
6%
Symptomatic Treatment
6%
Patient-Reported Outcome
6%
Cytotechnology
6%
Immunity
6%
Induced Pluripotent Stem Cell
6%
Population
6%
Cancer Mortality
6%
Disease
6%
Prognostic Factor
6%
Metastatic Carcinoma
6%
Intensive Care
6%
Prostate Specific Antigen
6%
Postoperative Complication
6%
Immunohistochemistry
6%
Clinical Trial
6%
Implant
6%
microRNA
6%
Autoimmunity
6%
Acute Coronary Syndrome
6%
Prostatectomy
6%
Conservative Treatment
6%
Cesarean Section
6%
Mortality Rate
5%
Prospective Study
5%
Antibiotics
5%
Aortic Dissection
5%
Primary Health Care
5%
Sudden Cardiac Death
5%
Cross Sectional Study
5%
Genome Wide Association Study
5%